170 related articles for article (PubMed ID: 23987314)
1. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan.
Lu B; Huang D; Zheng H; Huang Z; Xu P; Xu H; Yin Y; Liu X; Li D; Zhang X
Carbohydr Polym; 2013 Oct; 98(1):36-42. PubMed ID: 23987314
[TBL] [Abstract][Full Text] [Related]
2. A novel melphalan polymeric prodrug: preparation and property study.
Li D; Lu B; Huang Z; Xu P; Zheng H; Yin Y; Xu H; Liu X; Chen L; Lou Y; Zhang X; Xiong F
Carbohydr Polym; 2014 Oct; 111():928-35. PubMed ID: 25037433
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and antitumor evaluation of CMCS-DTX conjugates as novel delivery platform for docetaxel.
Liu F; Feng L; Zhang L; Zhang X; Zhang N
Int J Pharm; 2013 Jul; 451(1-2):41-9. PubMed ID: 23608199
[TBL] [Abstract][Full Text] [Related]
4. Water-soluble porphyrin-PAMAM-conjugates of melphalan and their anticancer activity.
Ramírez-Arroniz JC; Martínez Klimova E; Pedro-Hernández LD; Organista-Mateos U; Cortez-Maya S; Ramírez-Ápan T; Nieto-Camacho A; Calderón-Pardo J; Martínez-García M
Drug Dev Ind Pharm; 2018 Aug; 44(8):1342-1349. PubMed ID: 29521131
[TBL] [Abstract][Full Text] [Related]
5. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization and in vitro studies of pegylated melphalan conjugates.
Ajazuddin ; Alexander A; Amarji B; Kanaujia P
Drug Dev Ind Pharm; 2013 Jul; 39(7):1053-62. PubMed ID: 22779444
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of a hyaluronic acid-quantum dots-melphalan conjugate.
Xu H; He J; Zhang Y; Fan L; Zhao Y; Xu T; Nie Z; Li X; Huang Z; Lu B; Xu P
Carbohydr Polym; 2015 May; 121():132-9. PubMed ID: 25659681
[TBL] [Abstract][Full Text] [Related]
8. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
9. Folate-polyethylene glycol conjugated carboxymethyl chitosan for tumor-targeted delivery of 5-fluorouracil.
Li HL; He YX; Gao QH; Wu GZ
Mol Med Rep; 2014 Mar; 9(3):786-92. PubMed ID: 24469407
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
Yang L; Chen L; Zeng R; Li C; Qiao R; Hu L; Li Z
Bioorg Med Chem; 2010 Jan; 18(1):117-23. PubMed ID: 19959368
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
Shelma R; Sharma CP
Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291
[TBL] [Abstract][Full Text] [Related]
12. Development and activities of a new melphalan prodrug designed for tumor-selective activation.
Kerr DE; Li Z; Siemers NO; Senter PD; Vrudhula VM
Bioconjug Chem; 1998; 9(2):255-9. PubMed ID: 9548542
[TBL] [Abstract][Full Text] [Related]
13. Novel synthesis and in vitro drug release of polymeric prodrug: Chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
Yang L; Zeng R; Li C; Li G; Qiao R; Hu L; Li Z
Bioorg Med Chem Lett; 2009 May; 19(9):2566-9. PubMed ID: 19328686
[TBL] [Abstract][Full Text] [Related]
14. Polymeric anticancer drugs with pH-controlled activation.
Ulbrich K; Subr V
Adv Drug Deliv Rev; 2004 Apr; 56(7):1023-50. PubMed ID: 15066758
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate.
Alexander A; Ajazuddin ; Khan J; Saraf S; Saraf S
J Pharm Pharmacol; 2014 Sep; 66(9):1240-50. PubMed ID: 24824413
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
Mohammed MO; Hussain KS; Haj NQ
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
[TBL] [Abstract][Full Text] [Related]
17. Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil.
Horo H; Das S; Mandal B; Kundu LM
Int J Biol Macromol; 2019 Jan; 121():1070-1076. PubMed ID: 30342947
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan.
Gong XY; Yin YH; Huang ZJ; Lu B; Xu PH; Zheng H; Xiong FL; Xu HX; Xiong X; Gu XB
Int J Pharm; 2012 Oct; 436(1-2):240-7. PubMed ID: 22750430
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates.
Alexander A; Saraf S; Saraf S
Drug Dev Ind Pharm; 2015; 41(12):1954-61. PubMed ID: 25678314
[TBL] [Abstract][Full Text] [Related]
20. The alkylating prodrug J1 can be activated by aminopeptidase N, leading to a possible target directed release of melphalan.
Wickström M; Viktorsson K; Lundholm L; Aesoy R; Nygren H; Sooman L; Fryknäs M; Vogel LK; Lewensohn R; Larsson R; Gullbo J
Biochem Pharmacol; 2010 May; 79(9):1281-90. PubMed ID: 20067771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
